shadow
The English version of the Public Search application constitutes an unofficial English translation and is provided for information purposes only.
No legal rights can therefore be derived from this translation. For the official application, please consult the Dutch, French or German versions of the Public Search application.


Establishment unit data

In general

Enterprise number:0793.113.273
Status of the entity:Active
Number of the establishment unit:2.337.737.216
Status of the establishment unit:Active
Start date:October 28, 2022
Name of the establishment unit: CANCER STATE THERAPEUTICS
Name in French, since October 28, 2022
Address of the establishment unit:
Rue Auguste Piccard   48
6041   Charleroi
Since October 28, 2022
Phone number:No information found in the CBE.
Fax:No information found in the CBE.
Email address:No information found in the CBE.
Web address:No information found in the CBE.
 
 

Authorisations

Licences registered with the Federal Agency for the Safety of the Food Chain (FASFC)  Click here
 
 

Version of Nacebel codes for activities 2008(1)

Main activity: 21.201 - Manufacture of medicaments
Since October 28, 2022
Main activity: 72.110 - Research and experimental development on biotechnology
Since October 28, 2022
Main activity: 72.190 - Other research and experimental development on natural sciences and engineering
Since October 28, 2022
Main activity: 74.909 - Other professional, scientific and technical activities
Since October 28, 2022
 
 

Version of the Nacebel codes for the NSSO-activities 2008(1)

Main activity: 72.110 - Research and experimental development on biotechnology
Since March 7, 2023
 
 
No data included in CBE.

(1)The EC-classification of the Nacebel codes has changed on 1/1/2008. Both the Nacebel codification of 2003 and 2008 are available in Public Search. The 2003 codes were valid until 31/12/2007. On 1/1/2008, the new codification became valid. This was a mere administrative conversion : no activities of the entity or establishment unit have thus been changed.